Oscar Health, Inc. (OSCR) experienced a significant surge of 9.64% during the pre-market session on Wednesday, reflecting strong positive investor sentiment.
The sharp upward movement follows regulatory filings revealing that CEO Mark Bertolini purchased approximately $11.9 million worth of the company's Class A common stock. Such substantial insider buying is typically interpreted by the market as a high-conviction bet on the company's future prospects, signaling confidence from top leadership.